L. Nuit, quand il se dresse, énorme silhouette, Croit voir un monde sombre éclore à l'horizon

H. Victor and L. , Nouvelle série XXV. Les montagnes 1877 BIBLIOGRAPHIE 1. Basnyat B, Murdoch DR. High-altitude illness. Lancet, pp.1967-74, 2003.

P. Bärtsch and E. Swenson, Acute High-Altitude Illnesses, New England Journal of Medicine, vol.368, issue.24, pp.2294-302, 2013.
DOI : 10.1056/NEJMcp1214870

H. Davies, PULMONARY ??DEMA OF HIGH ALTITUDE, The Lancet, vol.301, issue.7810, p.999, 1973.
DOI : 10.1016/S0140-6736(73)91638-3

P. Hackett and R. Roach, High-Altitude Illness, New England Journal of Medicine, vol.345, issue.2, pp.107-121, 2001.
DOI : 10.1056/NEJM200107123450206

P. Hackett and R. Roach, High Altitude Cerebral Edema, High Altitude Medicine & Biology, vol.5, issue.2, pp.136-182, 2004.
DOI : 10.1089/1527029041352054

C. Houston and J. Dickinson, CEREBRAL FORM OF HIGH-ALTITUDE ILLNESS, The Lancet, vol.306, issue.7938
DOI : 10.1016/S0140-6736(75)90735-7

R. Schoene, Illnesses at High Altitude, Chest, vol.134, issue.2, 2008.
DOI : 10.1378/chest.07-0561

A. Montgomery, J. Mills, and J. Luce, Incidence of acute mountain sickness at intermediate altitude, JAMA J Am Med Assoc Feb, vol.3261, issue.5, pp.732-736, 1989.

T. Kilner and S. Mukerji, Acute mountain sickness prophylaxis: Knowledge, attitudes, & behaviours in the Everest region of Nepal, Travel Medicine and Infectious Disease, vol.8, issue.6, pp.395-400, 2010.
DOI : 10.1016/j.tmaid.2010.09.004

M. Maggiorini, B. Bühler, M. Walter, and O. Oelz, Prevalence of acute mountain sickness in the Swiss Alps., BMJ, vol.301, issue.6756, pp.853-858, 1990.
DOI : 10.1136/bmj.301.6756.853

A. Luks, S. Mcintosh, C. Grissom, P. Auerbach, G. Rodway et al., Wilderness Medical Society Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness, Wilderness & Environmental Medicine, vol.21, issue.2, pp.146-55, 2010.
DOI : 10.1016/j.wem.2010.03.002

J. Gertsch, G. Lipman, P. Holck, A. Merritt, A. Mulcahy et al., Prospective, Double-Blind, Randomized, Placebo-Controlled Comparison of Acetazolamide Versus Ibuprofen for Prophylaxis Against High Altitude Headache: The Headache Evaluation at Altitude Trial (HEAT), Wilderness & Environmental Medicine, vol.21, issue.3
DOI : 10.1016/j.wem.2010.06.009

M. Greene, A. Kerr, I. Mcintosh, and R. Prescott, Acetazolamide in prevention of acute mountain sickness: a double-blind controlled cross-over study., BMJ, vol.283, issue.6295, pp.811-814, 1981.
DOI : 10.1136/bmj.283.6295.811

P. Hillenbrand, A. Pahari, Y. Soon, D. Subedi, R. Bajracharya et al., Prevention of Acute Mountain Sickness by Acetazolamide in Nepali Porters: A Double-Blind Controlled Trial, Wilderness and Environmental Medicine, vol.17, issue.2, pp.87-93, 2006.
DOI : 10.1580/1080-6032-17.2.87

N. Ritchie, A. Baggott, A. Todd, and W. , Acetazolamide for the Prevention of Acute Mountain Sickness???A Systematic Review and Meta???analysis, Journal of Travel Medicine, vol.19, issue.5, pp.298-307, 2012.
DOI : 10.1111/j.1708-8305.2012.00629.x

M. Maggiorini, H. Brunner-la-rocca, S. Peth, M. Fischler, T. Böhm et al., Both Tadalafil and Dexamethasone May Reduce the Incidence of High-Altitude Pulmonary Edema, Annals of Internal Medicine, vol.145, issue.7, pp.497-506, 2006.
DOI : 10.7326/0003-4819-145-7-200610030-00007

A. Ellsworth, E. Meyer, and E. Larson, Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier

E. Leshem, Y. Caine, E. Rosenberg, Y. Maaravi, H. Hermesh et al., Tadalafil and Acetazolamide Versus Acetazolamide for the Prevention of Severe High???Altitude Illness: Table 1, Journal of Travel Medicine, vol.19, issue.5, pp.308-318, 2012.
DOI : 10.1111/j.1708-8305.2012.00636.x

J. Jobe, B. Shukitt-hale, L. Banderet, and P. Rock, Effects of dexamethasone and high terrestrial altitude on cognitive performance and affect, Aviat Space Environ Med, vol.62, issue.8, pp.727-759, 1991.

J. Lafleur, M. Giron, M. Demarco, R. Kennedy, R. Belue et al., Cognitive Effects of Dexamethasone at High Altitude???, Wilderness & Environmental Medicine, vol.14, issue.1, pp.20-23, 2003.
DOI : 10.1580/1080-6032(2003)014[0020:CEODAH]2.0.CO;2

M. Fischler, M. Maggiorini, L. Dorschner, J. Debrunner, A. Bernheim et al., Dexamethasone But Not Tadalafil Improves Exercise Capacity in Adults Prone to High-Altitude Pulmonary Edema, American Journal of Respiratory and Critical Care Medicine, vol.180, issue.4, pp.346-52, 2009.
DOI : 10.1164/rccm.200808-1348OC

C. Siebenmann, K. Bloch, C. Lundby, Y. Nussbamer-ochsner, M. Schoeb et al., Dexamethasone Improves Maximal Exercise Capacity of Individuals Susceptible to High Altitude Pulmonary Edema at 4559???m, High Altitude Medicine & Biology, vol.12, issue.2, pp.169-77, 2011.
DOI : 10.1089/ham.2010.1075

J. Richalet, P. Gratadour, P. Robach, I. Pham, M. Déchaux et al., Sildenafil Inhibits Altitude-induced Hypoxemia and Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.171, issue.3, pp.275-81, 2005.
DOI : 10.1164/rccm.200406-804OC

H. Ghofrani, F. Reichenberger, M. Kohstall, E. Mrosek, T. Seeger et al., Sildenafil Increased Exercise Capacity during Hypoxia at Low Altitudes and at Mount Everest Base Camp, Annals of Internal Medicine, vol.141, issue.3, pp.169-77, 2004.
DOI : 10.7326/0003-4819-141-3-200408030-00005

S. Borloz and G. Gremion, Dopage chez les sportifs amateurs. Schweiz Z Für Sportmed, pp.21-23, 2013.

J. Fénéon, Automédication au cours de l'activité alpinisme chez les stagiaires en formation au métier de guide de haute montagne, 2014.

G. Röggla, M. Röggla, A. Zeiner, H. Röggla, E. Deusch et al., Amphetamine doping in leisure-time mountain climbing at a medium altitude in the Alps]. Schweiz Z Für Sportmed, pp.103-108, 1993.

A. Mondiale-antidopage, S. Gaillard, P. Dellasanta, L. Loutan, and B. Kayser, Available from: http://www.wadaama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited- list/2014/WADA-prohibited-list-2014-FR.pdf 32 Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up, Liste des Interdictions 2014, pp.2013410-2013419, 2004.

S. Jackson, J. Varley, C. Sellers, K. Josephs, L. Codrington et al., Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro, High Altitude Medicine & Biology, vol.11, issue.3, pp.217-239, 2010.
DOI : 10.1089/ham.2010.1003

P. Campíns-falcó, R. Herráez-hernández, and A. Sevillano-cabeza, Application of column-switching techniques to the determination of medium polarity drugs: determination of acetazolamide in urine, Journal of Chromatography B: Biomedical Sciences and Applications, vol.654, issue.1, pp.85-90, 1994.
DOI : 10.1016/0378-4347(94)00005-0

A. Luks and E. Swenson, Medication and Dosage Considerations in the Prophylaxis and Treatment of High-Altitude Illness, Chest, vol.133, issue.3, 2008.
DOI : 10.1378/chest.07-1417

M. Duclos, Evidence on ergogenic action of glucocorticoids as a doping agent risk. Phys Sportsmed, pp.121-128, 2010.

B. Subedi, J. Pokharel, T. Goodman, S. Amatya, L. Freer et al., Complications of Steroid Use on Mt Everest, Wilderness & Environmental Medicine, vol.21, issue.4, pp.345-353, 2010.
DOI : 10.1016/j.wem.2010.09.006

X. Matabosch, O. Pozo, N. Monfort, C. Pérez-mañá, M. Farré et al., Urinary profile of methylprednisolone and its metabolites after oral and topical administrations, The Journal of Steroid Biochemistry and Molecular Biology, vol.138, 2013.
DOI : 10.1016/j.jsbmb.2013.05.019

A. Luks, Which Medications Are Safe and Effective for Improving Sleep at High Altitude?, High Altitude Medicine & Biology, vol.9, issue.3, pp.195-203, 2008.
DOI : 10.1089/ham.2008.1025

M. Beaumont, D. Batéjat, C. Piérard, V. Beers, P. et al., Zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude, Sleep, vol.30, issue.11, pp.1527-1560, 2007.

M. Beaumont, D. Batéjat, O. Coste, V. Beers, P. Colas et al., Effects of Zolpidem and Zaleplon on Sleep, Respiratory Patterns and Performance at a Simulated Altitude of 4,000 m, Neuropsychobiology, vol.49, issue.3, pp.154-62, 2004.
DOI : 10.1159/000076723

J. Jouanin, C. Dussault, V. Beers, P. Piérard, C. Beaumont et al., Short Half-Life Hypnotics Preserve Physical Fitness and Altitude Tolerance During Military Mountainous Training, Military Medicine, vol.174, issue.9, pp.964-70, 2009.
DOI : 10.7205/MILMED-D-03-1708

A. Vermeeren, Residual Effects of Hypnotics, CNS Drugs, vol.19, issue.1, pp.297-328, 2004.
DOI : 10.2165/00023210-200418050-00003

G. Dubowitz, Effect of temazepam on oxygen saturation and sleep quality at high altitude: randomised placebo controlled crossover trial, BMJ, vol.316, issue.7131
DOI : 10.1136/bmj.316.7131.587

A. Nickol, J. Leverment, P. Richards, P. Seal, G. Harris et al., Temazepam at high altitude reduces periodic breathing without impairing next-day performance: a randomized cross-over double-blind study, Journal of Sleep Research, vol.61, issue.4, pp.445-54, 2006.
DOI : 10.1183/09031936.98.12020408

G. Röggla, B. Moser, and M. Röggla, Effect of temazepam on ventilatory response at moderate altitude, BMJ, vol.320, issue.7226, p.56, 2000.
DOI : 10.1136/bmj.320.7226.56

G. Röggla, M. Röggla, A. Wagner, D. Seidler, and A. Podolsky, Effect of low dose sedation with diazepam on ventilatory response at moderate altitude, Wien Klin Wochenschr, vol.106, issue.20, pp.649-51, 1994.

L. Reidy, B. Nolan, A. Ramos, H. Walls, and B. Steele, Zolpidem Urine Excretion Profiles and Cross-Reactivity with ELISA(R) Kits in Subjects Using Zolpidem or Ambien(R) CR as a Prescription Sleep Aid, Journal of Analytical Toxicology, vol.35, issue.5, pp.294-301, 2011.
DOI : 10.1093/anatox/35.5.294

P. Lafargue, H. Benech, P. Chaminade, E. Chegaray, C. Pierard et al., Study of urinary excretion of codeine and morphine after oral ingestion of codeine, Ann Pharm Fr, vol.53, issue.2, pp.66-74, 1995.

M. Valentini, M. Revera, G. Bilo, G. Caldara, G. Savia et al., Effects of Beta-Blockade on Exercise Performance at High Altitude: A Randomized, Placebo-Controlled Trial Comparing the Efficacy of Nebivolol versus Carvedilol in Healthy Subjects, Cardiovascular Therapeutics, vol.9, issue.4, 2012.
DOI : 10.1111/j.1755-5922.2011.00261.x

P. Agostoni, Considerations on Safety and Treatment of Patients with Chronic Heart Failure at High Altitude, High Altitude Medicine & Biology, vol.14, issue.2, 2013.
DOI : 10.1089/ham.2012.1117

M. Huestis, J. Mitchell, and E. Cone, Urinary Excretion Profiles of 11-Nor-9-Carboxy-??9-Tetrahydrocannabinol in Humans after Single Smoked Doses of Marijuana, Journal of Analytical Toxicology, vol.20, issue.6, pp.441-52, 1996.
DOI : 10.1093/jat/20.6.441

M. Mittleman, D. Mintzer, M. Maclure, G. Tofler, J. Sherwood et al., Triggering of myocardial infarction by cocaine. Circulation, pp.2737-2778, 1999.

S. Uzan and N. Chabbert-buffet, Cancer du sein chez l'homme. Société Eur Gynécologie [Internet]